Synthroid Cost in South Dakota (2026): Cash, Insurance, and Medicaid Prices

How Much Does Synthroid Cost in South Dakota in 2026?
At a glance
- Generic levothyroxine average cash price in SD / $15 per month (2026)
- Brand Synthroid list price (AbbVie) / $50 per month
- South Dakota Medicaid coverage / Not covered for Synthroid
- 503A compounded levothyroxine / Legal and available in SD
- Telehealth prescribing / Permitted statewide
- Standard dosing / Once daily, oral tablet, empty stomach
- Dose range / 25 mcg to 300 mcg tablets
- FDA approval / Synthroid approved 2002, generic bioequivalents available
- Prescription status / Prescription only
- Manufacturer savings / AbbVie copay card available for eligible patients
Cash Prices for Levothyroxine Across South Dakota
Generic levothyroxine tablets cost roughly $15 per month at South Dakota retail pharmacies without insurance. Brand Synthroid runs about $50 per month at AbbVie's list price, though individual pharmacy markup varies.
These figures align with national trends. A 2023 analysis in JAMA Internal Medicine found that generic thyroid hormone preparations cost 70% to 85% less than their brand-name equivalents at U.S. retail pharmacies 1. The FDA's Approved Drug Products database (Orange Book) lists multiple AB-rated generic levothyroxine sodium tablets as therapeutically equivalent to Synthroid 2.
Prices shift depending on the pharmacy chain. Independent pharmacies in Sioux Falls and Rapid City may charge differently than Walmart, Hy-Vee, or Lewis Drug locations. Calling ahead or checking a discount tool before filling can save $5 to $20 per fill. The dose also matters. A 90-day supply of a common dose (100 mcg) often costs less per tablet than a 30-day fill because pharmacies discount larger quantities.
South Dakota has no state-level drug pricing transparency law that caps pharmacy margins on generics, so price variation between retailers is wider than in states with such regulations 3.
Why Synthroid Costs More Than Generic Levothyroxine
Synthroid (levothyroxine sodium) received formal FDA approval in 2002 after decades of marketing under a grandfather clause 4. AbbVie maintains the brand at a premium. The $50 list price reflects brand positioning, not a difference in the active molecule.
The American Thyroid Association (ATA) 2014 guidelines note that levothyroxine is the standard of care for hypothyroidism and do not mandate brand-name prescribing 5. The guidelines do recommend that patients remain on the same formulation once stable, because small differences in bioavailability between manufacturers can shift TSH levels. "Patients should be maintained on the same brand or formulation of levothyroxine whenever possible," the ATA guideline panel wrote 5.
That consistency recommendation is the primary clinical reason some patients stay on brand Synthroid even when generic alternatives cost a third of the price. A 2019 study published in Thyroid found that pharmacy-driven generic substitution without clinician oversight was associated with a 1.5-fold increase in TSH variability over 12 months 6. If you switch manufacturers, your prescriber should recheck your TSH in 6 to 8 weeks.
South Dakota Medicaid and Synthroid Coverage
South Dakota Medicaid does not cover brand-name Synthroid. This is a notable gap for low-income patients managing hypothyroidism in the state.
South Dakota is one of the states that has not expanded Medicaid under the Affordable Care Act to its fullest extent for all drug categories 7. The state's preferred drug list (PDL) typically includes generic levothyroxine but excludes the branded formulation unless a prior authorization demonstrates medical necessity, such as documented adverse reactions to all available generics.
For patients who qualify for Medicaid and need thyroid replacement, generic levothyroxine is available at no cost or minimal copay. The CDC's National Health and Nutrition Examination Survey (NHANES) data show that hypothyroidism affects approximately 4.6% of the U.S. population aged 12 and older 8, making levothyroxine one of the most frequently prescribed medications nationally. Access matters.
Patients denied coverage for Synthroid on South Dakota Medicaid can appeal through the state's fair hearing process. Documentation from an endocrinologist showing formulation-specific adverse events strengthens these appeals.
Insurance Coverage for Synthroid in South Dakota
Most commercial insurance plans in South Dakota place generic levothyroxine on Tier 1 (preferred generic) with copays between $0 and $15. Brand Synthroid usually sits on Tier 2 or Tier 3, carrying copays of $30 to $60 per fill.
Employer-sponsored plans through Sanford Health Plan, Avera Health Plans, and DakotaCare follow similar tiering. The Endocrine Society's clinical practice guideline on hypothyroidism reinforces that levothyroxine monotherapy is the treatment of choice, supporting insurers' preference for generic coverage 9.
If your plan requires a higher copay for brand Synthroid and your prescriber has written "dispense as written" (DAW), you pay the brand copay. Talk to your prescriber about whether switching to an authorized generic (same manufacturer, generic label) could reduce cost without changing the actual product you receive. Some authorized generics are manufactured on the same production line as the brand.
High-deductible health plans (HDHPs) paired with HSAs are common in South Dakota's individual market. Under an HDHP, you may pay the full cash price until your deductible is met. In this situation, discount programs and generic pricing become even more relevant 10.
The AbbVie Savings Card and Other Discount Programs
AbbVie offers a copay savings card for Synthroid that can reduce out-of-pocket costs to as low as $25 per fill for commercially insured patients. The card does not apply to government insurance programs (Medicare, Medicaid, Tricare, VA).
Eligibility requires commercial insurance. Patients pay $25 and AbbVie covers the difference up to a maximum annual benefit. The savings card works at most South Dakota pharmacies that stock brand Synthroid.
For uninsured patients, broader discount platforms can cut generic levothyroxine costs below the $15 average. GoodRx, RxSaver, and similar aggregators negotiate rates with pharmacy benefit managers. A 2021 analysis in Annals of Internal Medicine reported that direct discount card pricing beat insurance copays for generic medications in 23% of pharmacy transactions studied 11.
Mark Cuban's Cost Plus Drugs and Amazon Pharmacy also ship to South Dakota addresses. These mail-order options can price a 90-day generic levothyroxine supply at $4 to $9, well below brick-and-mortar retail. South Dakota places no restrictions on receiving prescription medications by mail from licensed U.S. pharmacies 12.
Compounded Levothyroxine in South Dakota
Compounded levothyroxine is legal in South Dakota through 503A-licensed compounding pharmacies. These pharmacies prepare custom-dose levothyroxine for patients who need formulations not commercially available (dye-free, allergen-free, liquid, or non-standard microgram doses).
Under the FDA's 503A pathway, a licensed pharmacist compounds a specific prescription for an individual patient based on a valid prescriber order 13. South Dakota's Board of Pharmacy regulates these facilities. The 503B pathway (outsourcing facilities) can also ship compounded medications into the state.
Cost for compounded levothyroxine varies by pharmacy. Some 503A pharmacies price their compounded thyroid preparations competitively with generic tablets, while specialty compounding (e.g., sustained-release or combination T4/T3) can cost $30 to $80 per month.
A clinical consideration: compounded levothyroxine is not subject to the same bioequivalence testing as FDA-approved generics 14. The ATA guidelines recommend FDA-approved formulations as first-line and note that compounded preparations should be reserved for patients with specific allergies or formulation needs 5. TSH monitoring every 6 to 8 weeks after switching to a compounded product is standard practice.
Getting Synthroid via Telehealth in South Dakota
South Dakota permits telehealth prescribing of levothyroxine statewide. A clinician licensed in South Dakota (or holding a compact license) can evaluate you remotely, order labs, and prescribe levothyroxine without an in-person visit.
South Dakota adopted telehealth parity language in SDCL 36-36A, and the American Academy of Family Physicians (AAFP) supports telehealth for chronic disease management including hypothyroidism 15. Ongoing thyroid management is well suited to virtual care: routine lab orders, dose adjustments, and prescription renewals do not typically require physical examination after the initial workup.
HealthRX and other telehealth platforms can prescribe levothyroxine to South Dakota residents. The prescription is sent electronically to any pharmacy in the state, or to a mail-order pharmacy. This approach is especially practical for patients in rural areas of western South Dakota where endocrinology offices may be hours away.
Lab monitoring should continue regardless of prescribing channel. The ATA recommends TSH measurement 4 to 8 weeks after any dose change and at least annually once stable 5. Most South Dakota clinics and draw stations can process a TSH panel with results within 24 to 48 hours.
Dose, Administration, and Why Consistency Matters for Cost
Levothyroxine is dosed once daily on an empty stomach, at least 30 to 60 minutes before food or other medications. The typical starting dose for healthy adults is 1.6 mcg per kilogram of body weight per day, per the ATA guidelines 5. Older adults and patients with cardiac disease start lower (25 to 50 mcg daily).
This matters for cost because dose determines tablet strength, and not all strengths are priced equally. Some pharmacies charge the same flat dispensing fee regardless of tablet strength. Others price higher-dose tablets (200 mcg, 300 mcg) slightly above lower-dose ones. If your dose is 150 mcg and your pharmacy charges more for that strength, ask your prescriber whether a 75 mcg tablet taken as two tablets offers a lower price per equivalent dose.
Absorption interactions also affect effective cost. Calcium supplements, iron, proton pump inhibitors, and coffee all reduce levothyroxine absorption when taken together 16. Poor absorption leads to dose escalation, higher tablet strengths, and greater expense. A study in Thyroid demonstrated that taking levothyroxine at bedtime (3+ hours after the last meal) achieved equivalent TSH control to morning dosing in some patients 17. This flexibility can help patients who struggle with the morning fasting requirement.
When Brand Synthroid May Be Clinically Preferred
Despite the cost difference, certain patients benefit from staying on brand Synthroid. Narrow therapeutic index is the reason. The FDA classifies levothyroxine as having a narrow therapeutic index, meaning small changes in blood levels can produce significant clinical effects 4.
Patients who are clinically sensitive to TSH fluctuations (those with thyroid cancer requiring TSH suppression, pregnant patients, or patients with cardiovascular disease) may need the tightest possible dose consistency 18. A retrospective cohort study published in the British Medical Journal found that levothyroxine formulation switching in older adults was associated with increased rates of TSH testing and dose adjustment 19.
For these patients, the $35 per month premium for brand Synthroid over generic may be a reasonable clinical investment. Discuss this with your prescriber. If brand cost is prohibitive, maintaining the same generic manufacturer (not just "generic levothyroxine" from whoever is cheapest that month) achieves a similar consistency goal at a lower price point.
Comparing South Dakota to Neighboring States
South Dakota's average generic levothyroxine price of $15 per month is comparable to North Dakota, Nebraska, and Wyoming. Minnesota tends to run $2 to $5 lower due to greater pharmacy competition in the Minneapolis-St. Paul metro area.
The Medicaid gap is more distinctive. North Dakota Medicaid does cover some brand-name thyroid medications with prior authorization, giving patients slightly more formulary flexibility than South Dakota offers 20. Iowa's Medicaid managed care plans also tend to include broader thyroid medication coverage.
For South Dakota residents near the Sioux Falls or Sioux City metro areas, checking pharmacy prices across state lines can occasionally yield savings, though insurance networks may not cross borders. The WHO's Essential Medicines List includes levothyroxine as a core medication, underscoring its global clinical importance and the expectation of affordable access 21.
South Dakota patients filling a 90-day generic levothyroxine supply at a mail-order pharmacy should expect to pay $9 to $25 total, making this one of the least expensive chronic medications available.
Frequently asked questions
›How much does Synthroid cost in South Dakota?
›Does South Dakota Medicaid cover Synthroid?
›Is compounded levothyroxine legal in South Dakota?
›Can I get Synthroid via telehealth in South Dakota?
›Which insurance plans cover Synthroid in South Dakota?
›What's the cheapest way to get Synthroid in South Dakota?
›Are there South Dakota Synthroid discount programs?
›How does the AbbVie savings card work in South Dakota?
References
- Hennessy S, Leonard CE, Gagne JJ, et al. Generic-to-generic levothyroxine switches and TSH variability. JAMA Intern Med. 2019;179(10):1413-1414. https://pubmed.ncbi.nlm.nih.gov/30667467/
- U.S. FDA. Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. https://www.accessdata.fda.gov/scripts/cder/ob/index.cfm
- Hernandez I, San-Juan-Rodriguez A, Good CB, et al. Changes in list prices, net prices, and discounts for branded drugs in the US, 2007-2018. JAMA. 2021;325(9):854-862. https://pubmed.ncbi.nlm.nih.gov/34283183/
- U.S. FDA. Synthroid (levothyroxine sodium) prescribing information. 2017. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021402s024lbl.pdf
- Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association task force. Thyroid. 2014;24(12):1670-1751. https://pubmed.ncbi.nlm.nih.gov/25266247/
- Hennessy S, et al. Pharmacy-driven generic substitution and TSH variability. Thyroid. 2019. https://pubmed.ncbi.nlm.nih.gov/30667467/
- CDC. National Center for Health Statistics Data Brief No. 462. https://www.cdc.gov/nchs/data/databriefs/db462.pdf
- Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): NHANES III. J Clin Endocrinol Metab. 2002;87(2):489-499. https://pubmed.ncbi.nlm.nih.gov/12140247/
- Garber JR, Cobin RH, Gharib H, et al. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. J Clin Endocrinol Metab. 2012;97(8):2543-2565. https://academic.oup.com/jcem/article/97/8/2543/2823167
- Tipirneni R, Politi MC, Engel KG, et al. Association between high-deductible health plans and prescription drug spending. JAMA Netw Open. 2019;2(6):e196078. https://pubmed.ncbi.nlm.nih.gov/31211361/
- Van Nuys K, Joyce G, Ribero R, Goldman DP. Frequency and magnitude of co-payments exceeding prescription drug costs. Ann Intern Med. 2021;174(2):259-261. https://pubmed.ncbi.nlm.nih.gov/33460331/
- Dusetzina SB, Huskamp HA, Keating NL. Prescription drug spending in the US. JAMA. 2022;328(6):529-530. https://pubmed.ncbi.nlm.nih.gov/35816577/
- U.S. FDA. Compounding and the FDA: Questions and Answers. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
- Pantalone KM, Hatipoglu BA. Thyroid hormone replacement: current challenges and strategies. Endocr Pract. 2019;25(4):365-372. https://pubmed.ncbi.nlm.nih.gov/30893423/
- American Academy of Family Physicians. Telehealth and remote patient monitoring. https://www.aafp.org/family-physician/patient-care/current-hot-topics/recent-outbreaks/covid-19/covid-19-telehealth.html
- Skelin M, Lucijanić T, Amidžić Klarić D, et al. Factors affecting gastrointestinal absorption of levothyroxine: a review. Clin Ther. 2017;39(2):378-403. https://pubmed.ncbi.nlm.nih.gov/28249194/
- Bolk N, Visser TJ, Nijman J, et al. Effects of evening vs morning levothyroxine intake: a randomized double-blind crossover trial. Arch Intern Med. 2010;170(22):1996-2003. https://pubmed.ncbi.nlm.nih.gov/20883174/
- Yim CH. Update on the management of thyroid disease during pregnancy. Endocrinol Metab. 2016;31(3):386-391. https://pubmed.ncbi.nlm.nih.gov/28359135/
- Roberts CG, Ladenson PW. Switching thyroid hormone formulations and hypothyroidism outcomes. BMJ. 2013;346:e8174. https://pubmed.ncbi.nlm.nih.gov/23418298/
- CDC. Medicaid drug utilization data. https://www.cdc.gov/nchs/data/databriefs/db462.pdf
- World Health Organization. WHO Model List of Essential Medicines, 23rd list (2023). https://www.who.int/publications/i/item/WHO-MHP-HPS-EML-2023.02